Cracking the code
Correspondence:
- 1.
- Wells HG. The Island of Dr Moreau. London: Heinemann, 1960.
- 2.
- Cardon LR, Watkins H. Waiting for the working draft from the humangenome project. BMJ 2000; 320: 1223-1224.
- 3.
- Zimmern RL. The human genome project: A false dawn? BMJ1999; 319: 1282.
- 4.
- van Ommen GJB, E Bakker, den Dunnen JT. The Human Genome Project andthe future of diagnostics, treatment, and prevention.Lancet 1999; 354 (suppl 1): 5-10.
- 5.
- Barroso I, Gurnell M, Crowley VEF, et al. Dominant negativemutations in human PPARgamma associated with severe insulinresistance, diabetes mellitus and hypertension. Nature1999; 402: 880-883.
- 6.
- Kuivenhoven JA, Jukema JW, Zwinderman AH, et al. The role of a commonvariant of the cholesteryl ester transfer protein gene in theprogression of coronary atherosclerosis. N Engl J Med 1998;338: 86-93.
- 7.
- Nebert DW. Polymorphisms in drug-metabolising enzymes: What istheir clinical relevance and why do they exist? Am J Hum Genet1997; 60: 265-271.
- 8.
- Martinelli I, Sacchi E, Landi G, et al. High risk of cerebral-veinthrombosis in carriers of a prothrombin-gene mutation and in users oforal contraceptives. N Engl J Med 1998; 338: 1793-1797.
- 9.
- Trent RJA. Milestones of the Human Genome Project: genesis to postgenome. Med J Aust 2000; 173: 591-594.
- 10.
- Sutherland GR. Just how long can we live? Med J Aust 2000;173: 594-596.
- 11.
- Hassan R. Social consequences of manufactured longevity. MedJ Aust 2000; 173: 601-603.
- 12.
- Kirby MD. The Human Genome Project in the dock. Med J Aust2000; 173: 599-600.
- 13.
- Stott Despoja N. The Human Genome Project: how do we protectAustralians? Med J Aust 2000; 173: 596-598.
Online responses are no longer available. Please refer to our instructions for authors page for more information.